GGrantIndex
Sort

59,101 grants matching hypertension

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

$3,314,109
Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

Phase 1 and 2 studies of sublingual dexmedetomidine, an alpha 2 adrenergic agonist, for treating opioid withdrawal

$3,312,204
Frances Rudnick Levin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · UG3 · FY2022 · DA

Technical development of cardiovascular Magnetic Resonance Imaging

$3,309,929
Michael Sack · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Scanning Probe Microscopy for the Intramural Research Community

$3,287,769
Emilios K Dimitriadis · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB

Genetic epidemiology of complex diseases

$3,285,133
Charles Rotimi · National Human Genome Research Institute · ZIA · FY2018 · HG

Physiology, Psychology, and Genetics of Obesity

$3,284,702
Jack A. Yanovski · Child Health And Human Development · Z01 · FY2007 · HD

Leveraging 30 years of Alzheimer's disease clinical trials data to decipher phenotypic response to treatment

$3,281,385
Judy Pa · University Of California, San Diego · RF1 · FY2024 · AG

Autophagy and Intracellular Trafficking in Placental Biology

$3,280,562
Carlos Guardia · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Reducing racial disparities in AD/ADRD: Addressing structural discrimination and resilience

$3,275,000
Sarah L Szanton · Johns Hopkins University · DP1 · FY2020 · AG

Etiology of Geographic and Racial Differences in Stroke

$3,274,393
George Howard · University Of Alabama At Birmingham · U01 · FY2017 · NS

SCCOR in Cardiac Dysfunction and Disease

$3,271,519
Louis Joseph Dell'italia · University Of Alabama At Birmingham · P50 · FY2006 · HL

Familial Intracranial Aneurysm Study II (FIA II)

$3,270,460
Joseph Paul Broderick · University Of Cincinnati · R01 · FY2009 · NS

Mechanistic characterization of genes for hypertension and renal disease.

$3,265,853
Howard J Jacob · Medical College Of Wisconsin · RC2 · FY2010 · HL

GENERAL CLINICAL RESEARCH CENTER

$3,263,457
Charles Ginsburg · Ut Southwestern Medical Center · M01 · FY2006 · RR

SCCOR in Cardiac Dysfunction and Disease

$3,251,049
Louis Joseph Dell'italia · University Of Alabama At Birmingham · P50 · FY2007 · HL

Familial Intracranial Aneurysm Study

$3,250,935
University Of Cincinnati · R01 · FY2004 · NS

Integrating Addiction Research in Health Systems: The Addiction Research Network

$3,246,804
Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2019 · DA

New Mexico IDeA Networks of Biomedical Research Excellence

$3,244,149
Jeffrey B Arterburn · New Mexico State University Las Cruces · P20 · FY2007 · RR

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study

$3,243,500
Kimberly Lee Drews · George Washington University · U01 · FY2015 · DK

Novel Therapies of Chronic Allograft Dysfunction

$3,241,031
Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2007 · AI

NIDA Clinical Trials Network: Big South/West Node (CTN-0159)

$3,235,924
Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2025 · DA

Diabetes and brain amyloid in middle aged Hispanics

$3,234,050
Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2021 · AG

GENERAL CLINICAL RESEARCH CENTER

$3,231,435
Georgetown University · M01 · FY2003 · RR

Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)

$3,229,538
Adnan Iqbal Qureshi · University Of Minnesota · U01 · FY2010 · NS

Novel Therapies of Chronic Allograft Dysfunction

$3,228,624
Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2008 · AI